Ashford Capital Management’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Ashford Capital Management's WGS Position: Q2 2026 in Review
Ashford Capital Management increased its GeneDx Holdings (WGS) stake by 16% in Q2 2026, buying an estimated $1.56M and bringing the position to 201,986 shares worth $13.9M. The position accounts for 1.49% of the portfolio, ranked #26.
Ashford Capital Management first reported a position in WGS in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.2M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Ashford Capital Management held 201,986 shares of GeneDx Holdings worth $13.9M as of Q2 2026.
- Ashford Capital Management bought 27,474 GeneDx Holdings shares in Q2 2026, an estimated $1.56M.
- GeneDx Holdings made up 1.49% of Ashford Capital Management's portfolio in Q2 2026, its #26 holding.
- Ashford Capital Management first reported a position in GeneDx Holdings in Q1 2025 and has held it in 6 quarters since.
- Ashford Capital Management's GeneDx Holdings position peaked at $17.2M in Q4 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Ashford Capital Management's 13F filing for Q2 2026, filed 21 Aug 2026.